CD44 and familial pancreatic carcinoma: For example, Li C et al. reported that CD44+CD24+ESA+ cells account for ~0.2–0.8% of all pancreatic cancer cells possessing properties of stem cells, which exhibit a 100‐fold increased tumorigenic potential compared with CD44−CD24−EpCAM− cells.8